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ABSTRACT 
Objective: The present study was designed to evaluate the effectiveness of the poly photo formulation for its learning and memory activity.  
Methods: The Indian origin test drug, FM7 phyto formulation compose of Convolulus pluricaulis, Habiscus rosasinnsis, Withania somnifera, 
Terminalia arjuna and Emblica officinalis, having the potential effect to improving memory studied at a dose of 50 mg and 100 mg/kg p. o. by using 
three different animal model like Elevated plus maze (EPM), Morris water maze (MWM) and Pole Climbing apparatus (PCA) for the effect of 
nootropic action; against standard drug Bacopa monnieri evaluated on the basis of transfer latency reduction on a rat, before and after drug 
administration.  
Results: On treatment with polyherbal formulation FM7 showed a significant effect on enhancing learning and memory properties. It was observed 
that significant (p<0.001) reduction in transfer latency in Elevated Plus Maze, Morris Water Maze test and escape latency in Pole Climbing 
Apparatus test as compared with the control; as well as standard Bacopa monnieri.  
Conclusion: The polyphyto formulation FM7 composed of (Convolulus pluricaulis 20%, Habiscus rosasinnsis 20%, Withania somnifera 20%, 
Terminalia arjuna 20% and Emblica officinalis 20%) found to be safe and effective in enhancing learning and memory properties. 
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The loss of memory in Dementia or in Alzheimer’s disease is the 
main challenges of treatment. Traditional Indian origin Nootropic 
drugs (smart drugs), use to improve human cognitive abilities and 
improve learning and memory function. Typically these are work by 
increasing the brain’s supply of neurochemicals, increase perfusion 
of brain’s oxygen or by activating nerve growth [1]. Memory is the 
ability of the individual to record the sensory stimulant information 
and events retain them over a short or a long period of time and 
recall the same at a later when it is needed. Poor memory, less 
attention, and slow learning are quite natural problems among 
students and old age people. Herbal medicine for improving memory 
and treat memory disorder have been urgent need of findings 
because natural remedies were shown promising effect believes in 
working by different pathophysiology and preventing brain's 
degeneration. Indian system of medicine reported that use of herbs, 
nutraceuticals of lifestyle changes important for controlling age-
related neurodegenerative disorders [2]. 
INTRODUCTION 
The present study was focused upon exploring the potential of 
polyphyto formulation to improve memory; it includes 
‘‘Shankhpushpi’’ (Convolulus pluricaulis), ‘‘Japapushpa’’ (Habiscus 
rosasinnsis), “Ashwagandha” (Withania somnifera), ‘‘Arjuna’’ 
(Terminalia arjuna) and “Amla” (Emblica officinalis). C. pluricaulis 
(Shankhpushpi) is used for the treatment of various disorders 
mainly nervous weakness, like insomnia, mental as well as physical 
fatigue, loss of memory, etc. C. pluricaulis is generally recommended 
as a brain tonic [3,4]. Convolvulus pluricaulis contain glycosides, 
coumarins, flavonoids and alkaloids whereas the alkaloid has been 
recognized as an active principle [5]. Flowers of Habiscus rosasinnsis 
use as refrigerant" emollient and emmenagogue, aphrodisiac; 
decoction given in bronchial catarrh; infusion of petals use as a 
demulcent in a cough and useful in strangury, cystitis, and other 
genitourinary troubles. It also reported to have a positive effect on 
learning and memory model [6] 3, 7-diglucoside, Quercetin-3-
diglucoside, cyanidin-3-sophoroside-5-glucoside, and diglucoside 
have been isolated from deep yellow flowers; moreover, 
kaempferol-3-xylosylglucoside have been identified from ovary 
white flowers [7]. Withanolide A (WL-A) is a major constituent of 
Ashwagandha, especially reported for action like normal cortical 
neurons, predominant axonal outgrowth [8] and can be used for 
neurodegenerative diseases [9]. It stimulates the growth of axons and 
dendrites in human neuroblastoma cells and in rat neurons [10,11], 
and enhances cognition and improve memory effects [12, 13].  
Terminalia arjuna used by Ayurvedic physicians for its curative 
properties in heart problems like angina, hypertension, and 
coronary artery disease. Terminalia arjuna is having antioxidant 
action as it contains flavonoids and oligomeric proanthocyanidins 
[14]. Terminalia arjuna provides strength to the nervous system and 
also strengthens the reflexes [15]. The fruits of Emblica officinalis 
are widely used in the Aryuveda and it increases defense against 
diseases in our body. It has its beneficial role in anemia, diabetes, 
liver treatment, cancer, heart trouble, ulcer, and various other 
diseases. It has recommended as an analgesic, antipyretic, 
antioxidant [16], antitussive, immunomodulatory, cytoprotective 
[17], and gastroprotective [18]. Amla is a natural remedy to improve 
memory function [19].  
Standard drug as Bacopa monnieri [20] 
Bacopa monnieri has been shown to be very useful in improving 
learning and memory [21, 22]. Bacopa monnieri, a member of the 
Scrophulariaceae family, is a small, creeping herb with numerous 
branches, small oblong leaves, and light purple flowers [23]. It has 
been used in Ayurvedic medicine and traditional treatments for a 
number of disorders, particularly those involving anxiety, intellect, 
and poor memory [24]. The plant has prominent action on the 
central nervous system, where it improves understanding, memory, 
intellect, and speech, and corrects aberrations of emotions, mood, 
and personality of an individual. Animal studies have found Bacopa 
monnieri attenuates scopolamine-induced dementia, and 
anticholinesterase activity has been demonstrated [25]. Preclinical 
and clinical studies have shown that Bacopa monnieri improves 
memory and mental function [26]. The plant, plant extracts and 
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isolated bacosides have been investigated for nootropic activity. A 
recent study reveals B. monnieri extract is able to reduce amyloid 
levels in PSAPP mice which is a transgenic mice expressing the 
“Swedish” amyloid precursor protein and M146L presenilin-1 
mutations [27]. The present study was designed to evaluate the 
effectiveness of the poly photo formulation having nootropic agents 
for its learning and memory activity. 
MATERIALS AND METHODS 
Plant material and preparation of formulation 
Different parts of all plants were obtained from Dehradun, India and 
were identified and authenticated by the department of botany, Sri 
Venkateswara University, Tirupati. The voucher specimen number 
of Bacopa monnieri was 1052. Various Plant parts were air dried in 
the dark, and grounded into a fine powder and passes it through a # 
100 sieve, then prepared a formulation FM7 according to their 
composition shown in table no. 1. 
Experimental animals 
Adult albino wistar strain rats (120±20 Gms) of either sex were 
procured and were grouped randomly. The male and female rats 
were separated and were acclimatized for one week in the animal 
house facility. They were housed in polypropylene cages in an 
ambient temperature of 25±1 °C with a natural dark-light cycle. The 
animals had been provided standard pellet diet and water given ad 
libitum. All experiments were conducted in the daytime (9:30 AM to 
5:00 PM). The study was approved by the institutional ethics 




Table 1: The composition nootropic phyto formulation (FM7) 
Plant Sanskrit name Family Plant parts 100 gm Voucher specimen no. 
Convolulus pluricaulis Shankhpushpi Convolvulaceae Herbs 20 1222 
Habiscus rosasinnsis Japapushpa Malvaceae Flower 20 436 
Withania somnifera Ashwagandha Solanaceae Root 20 709 
Terminalia arjuna Arjuna Combretaceae Bark 20 405 
Emblica officinalis Amla Euphorbiaceae Fruit 20 1441 
 
Treatment groups 
After acclimatization, the animals were randomly divided into 
following groups consisting of n=6 rats each. All the groups received 
the vehicle, standard drug and the test drug one hour prior to each 
experiment. It was studied for Elevated Plus Maze test (EPM), Morris 
Water Maze Test (MWM), Pole Climbing Test (PCT).  
Group1: Control (Normal saline 1 ml/rat per oral) for MWM test 
Group2: Control (Normal saline 1 ml/rat per oral) for EPM test 
Group3: Control (Normal saline 1 ml/rat per oral) for PCA test 
Group4: Standard (Bacopa monnieri 50 mg/kg per oral) for MWM test 
Group5: Standard (Bacopa monnieri 50 mg/kg per oral) for EPM test 
Group6: Standard (Bacopa monnieri 50 mg/kg per oral) for PCA test 
Group7: Standard (Bacopa monnieri 100 mg/kg per oral) for MWM test 
Group8: Standard (Bacopa monnieri 100 mg/kg per oral) for EPM test 
Group9: Standard (Bacopa monnieri 100 mg/kg per oral) for PCA test 
Group10: Test FM7 (50 mg/kg per oral) for MWM test 
Group11: Test FM7 (50 mg/kg per oral) for EPM test 
Group12: Test FM7 (50 mg/kg per oral) for PCA test 
Group13: Test FM7 (100 mg/kg per oral) for MWM test 
Group14: Test FM7 (100 mg/kg per oral) for EPM test 
Group15: Test FM7 (100 mg/kg per oral) for PCA test 
Acute toxicity study  
To evaluate the acute toxicity of drugs after a single oral dose, Swiss 
albino rats fasted for 6 h with only water provided ad libitum. Rats 
were divided into experimental groups (n=6) and were treated 
orally at doses of 300, 1000 and 2000 mg/kg. The animals were then 
allowed free access to food and water. The animals were observed 
for any abnormal behavior, changes of body weight and mortality 
was noted for 14 d after the oral administration of formulation for 
the acute toxicity. The control group was treated with normal saline 
(1 ml/kg, i. p.). FM7 was found to be safe [28]. 
Experimental method 
Morris water mazes test 
The Morris water maze consisted large
Elevated plus maze test 
 circular pool, 1.50 m across 
and 0.60 m high filled with water, which was made opaque by 
adding milk. Water provided a uniform into amaze environment, 
thus eliminating any olfactory interference. A 28x10 cm rectangular 
escape platform was constructed of water resistant material and 
covered with a material that allows the animal to remain on top 
when it is submerged. The platform was 28 cm in height so that it 
could be submerged 2 cm below the level of water surface. The 
water temperature was maintained at 26±2 °C. The animals were 
given a daily session of three trials per day. Latency time to reach 
the platform was recorded in each trial. A significant decrease in 
latency times from that of the first session was considered as 
successful learning [29]. The group 1, 4, 7, 10, and 13 were used as 
control, standard (50 mg/kg), standard (100 mg/kg), FM7 (50 
mg/kg), and FM7 (100 mg/kg) respectively for MWM test.  
The elevated plus maze served as the exteroceptive behavioral 
model (wherein the stimulus existed outside the body) to evaluate 
learning and memory in rats. The apparatus consisted of two open 
arms (50 cm × 10 cm) and two covered arms (50 cm × 40 cm ×10 
cm). The arms extended from a central platform (10 cm×10 cm) and 
the maze was elevated to a height of 50 cm from the floor. On the 
first the day, each rat was placed at the end of the open arm, facing 
away from a central platform [30, 31]. With little modification 
transfer latency (TL) was taken at the time taken by the rat to move 
into any one of the covered arms enter with all its four legs where 
opposite gender of rat is placed in any one of the covered places to 
observe retentive memory of test rat come faster toward that area. 
TL was recorded on the first day for the each animal. The rat was 
allowed to explore the maze for another 2 min and returned to its 
home cage. Retention of this learned task was examined 24 h after 
the first-day trial [32]. The group 2, 5, 8, 11, and 14 were used as 
control, standard (50 mg/kg), standard (100 mg/kg), FM7 (50 
mg/kg), and FM7 (100 mg/kg) respectively for EPM test. 
Pole climbing test 
Cook’s Pole Climbing Apparatus use to study cognitive function, 
mainly a response to conditioned stimuli during learning & its 
retention. The apparatus has an experimental chamber (25 × 25 × 25 
cm) with the floor grid in a soundproof enclosure. Scrambled shock 
(6mA) is delivered to the grid floor of the chamber composed of 
stainless steel rods. A pole, 2.5 cm in diameter, hangs inside the 
chamber through a hole in the upper center of the chamber. The 
study rat was placed in the chamber and allowed to explore the 
chamber for 45 seconds. Conditioned stimulus (CS) i. e buzzer signal 
was turned on and unconditioned stimulus (US) i. e electric shock 
delivered through grid floor for 45 Sec. Animal learned to associate 
the buzzer with the impending foot shock and was capable of 
avoiding the foot shock by climbing the pole after buzzer signal. 
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Avoidance response was defined as climbing reaction time<10 sec 
only; and escape response was climbing after applying reaction 
time>10 sec. Every rat was subjected to maximum 05 trials on 1st 
day, and 24 h later, the rat was subjected to Relearning trials (2nd 
day 3 trials and on 3rd day one trial) and transfer latency was noted 
to check the retention of Conditioned Avoidance Response (CAR) 
and escape response.  
Animals were screened by using this model and those who 
demonstrated at least one escape response either on day one or two 
were included in the study [33]. The group 3, 6, 9, 12, and 15 were 
used as control, standard (50 mg/kg), standard (100 mg/kg), FM7 (50 
mg/kg), and FM7 (100 mg/kg) respectively for PC test. 
Statistical analysis 
Data was analyzed using one-way ANOVA and two-way repeated 
measures followed by Tukey's multiple comparisons and student’s 
unpaired t-test using the graphpadprism statistic software
RESULTS 
. P<0.05 
was set as statistically significant. 
Water maze test 
The transfer latency on a water maze test was studied using a 
circular pool (diameter 70 cm; height 28 cm) and a platform 
(diameter 3.8 cm) was placed 1.5 cm below the water level in the 
middle of a fixed quadrant. The differences in the transfer latency 
were noted in control, standard, and test group. Results indicated 
that test group animals at 50 mg and 100 mg doses of FM7 showed 
lesser transfer latency time in seconds during the study and found 
to be an extremely significant decrease in transfer latency 
(p<0.001) when compared to respective control groups and test 
group found to be much better than standard (Bacopa monnieri) 
per oral route (fig. 1). 
  
 
Fig. 1: The transfer latency of polyphyto formulations FM7 in rat in secs using MWM; ***=p<0.001 vs control 
 
Effect of transfer latency using elevated plus maze 
Transfer latency was defined as the time (in seconds) taken by the 
animal to move from the open arm into one of the covered arms with all 
its four legs. A little modification has been made that an opposite gender 
of rat is placed in any one of the covered places to observe retentive 
memory of all group of animals tested for whether it come faster toward 
that area where a different sex of animal kept. A significant decrease in 
transfer latency (TL), the value of retention, indicated improving 
memory. Test formulation FM7 at 50 mg and 100 mg dose showed a 
decrease in TL on the second day when compared to control groups 
indicating significant (p<0.001) memory improvement (fig. 2). FM7 
observed better than Standard drug in improving learning and memory.  
 
 
Fig. 2: Bar Graph of mean transfer latency in elevated plus maze 
using rat; ***=p<0.001 vs positive and negative control 
Pole climbing test 
To study the escape latency in seconds-rat placed inside the Pole 
climbing apparatus, a shock for controlled duration of 200V AC 50 
Hz single phase-0.2 mA was applied.  
The Test group FM7 at 50 mg doses revealed a statistically 
significant (p<0.01) and at 100 mg dose highly significantly 
(p<0.001) decrease in escape latency in pole climbing test as 
compared to the control and standard group (Bacopa monnieri) 
treated group (fig. 3).  
 
 
Fig. 3: Bar Graph of escape latency of rat in secs using pole 
climbing apparatus; ***=p<0.001 vs positive and negative 
control 
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DISCUSSION 
Poor memory, lower retention, and slow recall are common 
problems in today’s stressful and competitive world. The herbal 
drug has shown the promising effect in the treatment of memory 
loss. The herbs acting on the brain are called as Nootropic herbs 
(“Nootropic” is derived from Greek and means acting on the mind) 
and their isolated constituents referred to as smart drugs. Memory 
enhancer herbs enhance the memory and increase blood circulation in 
the brain. The herbs act either by improving memory or preventing 
neurodegeneration by antioxidant and anti-inflammatory activity [34].  
Morris Water Maze is a traditional tool in assessing learning and 
memory performance in laboratory animals. Originally designed to 
evaluate the antianxiety agents, elevated plus maze has also been 
recently extended to measure the long-term spatial memory in 
animals. Passive avoidance behavior is used to examine the long-
term memory based on negative reinforcement [35]. Elevated plus 
maze, Morris water maze (MWM) and Pole Climbing apparatus 
(PCA) were used to evaluate the effect of learning and memory 
improvement properties in the rat. 
Dose selection for in vivo study was made on the basis of acute 
toxicity studies (300, 1000 and 2000 mg/kg body weight) result and 
in consideration of estimating the human equivalent dose (HED) for 
treating the patient. The dose 50 mg/kg in rats, means 8 mg/kg in 
humans calculated by division method:  
mg/kg animal dose ÷ [Km human/Km animal] 
The drug dose 50 mg/kg or 100 mg/kg was found to be safe as well 
as effective for two novel poly photo herbal formulations, so it can 
use clinically at a dose range of 500 mg to 1000 mg to a 60 kg adult 
human [20].  
In MWM test observed that test group animal treated with 50 mg 
and 100 mg dose p. o of FM7 showed less transfer latency time (in 
seconds) during the study and found to be an extremely significant 
(p<0.001) when compared to control groups and much better than 
Bacopa monnieri for its nootropic action. In an Elevated plus maze 
test nootropic agent FM7 at 50 mg and 100 mg dose showed a 
decrease in transfer latency on the second day when compared to 
control and standard groups indicating significant (p<0.001) 
memory improvement. In another test model like pole climbing test 
revealed that the test group treated with FM7 (50 mg doses p. o) 
found to be statistically significant (p<0.001) compared to the 
control groups, while FM7 found that comparatively better than 
standard group. 
The herbal drugs like Convolulus pluricaulis, Habiscus rosasinnsis, 
Withania somnifera, Terminalia arjuna and Emblica officinalis have 
been reported good for nervous disorder, example C. pluricaulis is 
generally recommended as a brain tonic [3,4]; H. rosasinnsis good for 
learning and memory [6], W. somnifera can be used for 
neurodegenerative diseases [9]; T. arjuna strengthens the nervous 
system and the reflexes [15]; E. officinalis is a natural remedy to 
improve memory function [19]. The different herbs containing 
different plant constituent and their action in the brain was different 
from each other, eg. Withanolide A (WL-A) is a major constituent of 
Ashwagandha, especially reported for action like normal cortical 
neurons, predominant axonal outgrowth [8], T. arjuna having 
antioxidant action as it has flavonoids and oligomeric 
proanthocyanidins [14] reported for neurological action; 
Convolvulus pluricaulis contain glycosides, coumarins, flavonoids and 
alkaloids where the alkaloid has been recognized as active principle 
[5] etc. In the present study observed that the combination of 
traditionally use herbal drugs shown a synergistic effect in 
improving learning and memory. 
CONCLUSION 
The nootropic polyphyto FM7 formulation composed of (Convolulus 
pluricaulis 20%, Habiscus rosasinnsis 20%, Withania somnifera 20%, 
Terminalia arjuna 20% and Emblica officinalis 20%), having 
promising significant effect for enhancing learning and memory 
properties on per oral administration on a rat. The herbal plants 
such as (Convolulus pluricaulis, Habiscus rosasinnsis, Withania 
somnifera, Terminalia arjuna) its action are due to affinity of their 
phytoconstituents towards nervous system and neuron, Emblica 
officinalis act by anti-inflammatory activity in brain cell. Further 
research required on phytoconstituent and receptor model to 
understand the drug action. The FM7 having a synergistic effect can 
be used for memory loss or dementia and prophylactically use to 
prevent neuro-degeneration. 
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